SRDX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Surmodics to GTCR
29. Mai 2024 10:23 ET | Wohl & Fruchter LLP
We are investigating the fairness of the sale of Surmodics to GTCR for $43.00 per share in cash